BRKR - ブルカ― （Bruker Corporation） ブルカ―BRKRのチャート
BRKRの企業情報
| symbol | BRKR |
|---|---|
| 会社名 | Bruker Corp （ブルカ―） |
| 分野（sector） | Capital Goods 資本財（工業製品） |
| 産業（industry） | Biotechnology: Laboratory Analytical Instruments |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 ブルカー(Bruker Corporation)は生命科学、製薬、バイオテクノロジー、臨床と分子診断研究、及び様々な産業と政府用途での材料および化学分析分野における多様な顧客層の急速に変化するニーズに対応する科学機器のグローバルなメーカー。同社の技術プラットフォームは磁気共鳴技術、質量分析技術、ガスクロマトグラフィー技術、X線技術、スパーク発光分光分析法、原子間力顕微鏡法、スタイラス及び光学的測定技術、並びに赤外線とラマン分子分光法技術を含む。同社は化学・生物・放射性物質・核・爆発物（CBRNE）探知用の一連のフィールド分析システムを製造・販売する。平成24年4月、同社はSkyScan N.V.を買収した。 ブルカ―は、米国の生命科学関連の分析装置メ―カ―。最先端科学の研究に取り組む企業や研究機関へMRI（生体用核磁気共鳴装置）、EPR（電子常磁性共鳴装置）、X線回折装置・分析装置、ナノ表面分析システム、質量分析装置、赤外分光計・その周辺機器などを販売し、アフタ―サ―ビスを提供する。 Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with its customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. |
| 本社所在地 | 40 Manning Road Billerica MA 01821 USA |
| 代表者氏名 | Frank H. Laukien フランクH.ローキン |
| 代表者役職名 | Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者（CEO） |
| 電話番号 | +1 978-663-3660 |
| 設立年月日 | 33270 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 6200人 |
| url | www.bruker.com |
| nasdaq_url | https://www.nasdaq.com/symbol/brkr |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 313.30000 |
| 終値（lastsale） | 33.24 |
| 時価総額（marketcap） | 5196102727.2 |
| 時価総額 | 時価総額（百万ドル） 4914.725 |
| 売上高 | 売上高（百万ドル） 1841.5 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 4876.625 |
| 当期純利益 | 当期純利益（百万ドル） 160.70000 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Bruker Corporation revenues increased 9% to $875.4M. Net income increased 29% to $58.2M. Revenues reflect Bruker Scientific Instruments segment increase of 11% to $789.4M. Net income benefited from Bruker Scientific Instruments segment income increase of 21% to $82.9M Bruker Energy_Supercon Technologies segment income increase of 56% to $3.9M Eliminations segment income totaling $100K vs. $0K. |
BRKRのテクニカル分析
BRKRのニュース
Bruker Corporation: Bruker Launches New nanoElute 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape 2023 Software 2022/08/29 10:04:00 Finanz Nachrichten
New nanoElute 2 features nano-LC advances, supports automated single cell sample preparation from label-free ProteoCHIP on CellenONE platform MetaboScape 2023 advances fluxomics applications and i…
Bruker Launches New nanoElute 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape 2023 Software 2022/08/29 10:00:00 Wallstreet:Online
At the International Mass Spectrometry Conference (IMSC 2022), Bruker Corporation (Nasdaq: BRKR) today announced the launch of the new nanoElute 2 nano-LC, of MetaboScape and TASQ 2023 software supporting fluxomics, and of latest advances in PaSER’s intelligent acquisition to enhance research in protein-protein interactions (PPIs) and metaproteomics applications. This press release features
10 Stocks You Can Still Catch Before their Ex-Dividend Date 2022/08/29 09:25:44 TipRanks
Investors looking for a bargain might want to consider these 10 dividend stocks. Every stock on this list is near its 52-week lows, so this could present investors with a chance to buy the dip. What''s more, all of these stocks'' ex-dividend dates are coming up soon, so you still have a chance to grab some shares and benefit from their dividend distribution in the near future. Here is the full list: JWN, SPB, SLG, SSNC, UHS, BRKR, BAX, OTEX, SLM, SWK.
Bruker Corporation: Upside Is Limited From Here (NASDAQ:BRKR) 2022/08/24 19:01:29 Seeking Alpha
Foreign currency translation and issues regarding profitability have slowed Bruker''s progress rather considerably. See why I rate BRKR stock as a hold for now.
ILMN stock added to positive catalyst watch at Citi (NASDAQ:ILMN) 2022/08/22 17:43:13 Seeking Alpha
Citi analysts have added Illumina (ILMN) to its 90-day positive catalyst watch and upgraded Bruker Corporation (BRKR) after the life sciences companies reported Q2 2022 results early…
Bruker Corporation 2022 Q1 - Results - Earnings Call Presentation 2022/05/04 12:18:05 Seeking Alpha
The following slide deck was published by Bruker Corporation in conjunction with their 2022 Q1 earnings call.
Bruker Non-GAAP EPS of $0.49 beats by $0.07, revenue of $595M beats by $22.5M 2022/05/04 11:29:03 Seeking Alpha
Bruker press release (BRKR): Q1 Non-GAAP EPS of $0.49 beats by $0.07.Revenue of $595M (+7.3% Y/Y) beats by $22.5M.Shares +1.5% PM.
Bruker Reports First Quarter Financial Results 2022/05/04 11:00:00 Business Wire
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2022. First Quarter 2022 Financial Results Bruker’s revenues for the first quarter of 2022 were $595.0 million, an increase of 7.3% compared to $554.7 million in the first quarter of 2021. In the first quarter of 2022, revenues increased 10.5% organically year-over-year. Growth from acquisitions was 1.0%, while foreign currency transactions had a negative
Bruker Q1 2022 Earnings Preview 2022/05/03 16:07:57 Seeking Alpha
Bruker (BRKR) is scheduled to announce Q1 earnings results on Wednesday, May 4th, before market open.The consensus EPS Estimate is $0.42 (-4.5% Y/Y) and the consensus Revenue Estimate…
Bruker launches tests for detecting mycobacteria, sexually transmitted infections 2022/04/22 11:41:59 Seeking Alpha
Bruker (BRKR) said it launched new multiplex PCR infectious disease tests that are based on its LiquidArray technology
Bruker Launches Unique LiquidArray® Multiplex PCR Assays 2022/04/22 11:00:00 Business Wire
LISBON, Portugal--(BUSINESS WIRE)---- $BRKR #BRKR--At the 32nd European Congress of Clinical Microbiology & Infectious Diseases (www.eccmid.org), Bruker Corporation (Nasdaq: BRKR) announces further advances in its market-leading MALDI Biotyper® (MBT) platform, and launches new multiplex PCR infectious disease assays that are based on its proprietary LiquidArray® technology. Bruker further expands its mycobacteria portfolio with the FluoroType® Mycobacteria PCR assay, launched on the high-precision FluoroCy
Bruker Launches Unique LiquidArray Multiplex PCR Assays 2022/04/22 11:00:00 Wallstreet:Online
At the 32nd European Congress of Clinical Microbiology & Infectious Diseases (www.eccmid.org), Bruker Corporation (Nasdaq: BRKR) announces further advances in its market-leading MALDI Biotyper (MBT) platform, and launches new multiplex PCR infectious disease assays that are based on its proprietary LiquidArray technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220422005065/en/
Bruker Announces Date and Time of First Quarter 2022 Earnings Release and Webcast 2022/04/18 20:05:00 Business Wire
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2022 financial results before market opening on Wednesday, May 4, 2022. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q1 2022 Earnings Webcast” hyperlink in the “Events & Presentations” section. A slide presenta